This is a general term for tumors (growths) that start in one of the 12 cranial nerves. These can be non-cancerous (benign) or cancerous (malignant).
Every report comes from a Lived member, sent anonymously.
Have you had Radiosurgery for Cranial Nerve Tumors?
Cranial nerve tumors are growths that form on one of the twelve cranial nerves, the nerves that connect the brain directly to the eyes, ears, face, mouth and throat. Because each nerve has its own job, a tumor usually shows itself through what that nerve stops doing well: hearing and balance, feeling or movement in the face, eye movement, vision, swallowing or speech. Most cranial nerve tumors are schwannomas: benign (noncancerous), usually slow-growing tumors that arise from Schwann cells, the cells that wrap and insulate nerve fibers. By far the most common is the vestibular schwannoma, also called an acoustic neuroma, which grows on the nerve that carries hearing and balance signals from the inner ear to the brain. It typically causes hearing loss in one ear, ringing in that ear (tinnitus) and unsteadiness. Schwannomas can also form on the nerves for facial sensation, facial movement, eye movement, swallowing and the tongue. Optic pathway gliomas are a different kind of tumor that affects the nerve of sight, mostly in young children with neurofibromatosis type 1. Malignant (cancerous) cranial nerve tumors exist but are rare. Even a benign tumor matters because of where it sits. As it grows it can press on neighboring nerves and, if it becomes large, on the brainstem, the part of the brain that controls basic functions such as breathing and swallowing.
Most cranial nerve schwannomas are sporadic: a single tumor appears in someone with no family history, and no lifestyle cause has been identified. Vestibular schwannomas are linked to loss of function of a gene on chromosome 22 that normally keeps Schwann cell growth in check. They usually appear between the ages of 30 and 60. Tumors on both hearing nerves usually point to an inherited condition long called neurofibromatosis type 2 (NF2) and now called NF2-related schwannomatosis. People with it tend to develop symptoms in their teens or early adulthood and often have schwannomas on several cranial nerves, along with other brain and spinal cord tumors. About half inherit it from a parent and half have a new gene change, and each child of an affected parent has a 50 percent chance of inheriting it. Neurofibromatosis type 1, a separate inherited condition, raises the risk of optic pathway glioma in young children.
The symptoms of a vestibular schwannoma overlap with many common ear problems, so the clue that prompts a closer look is that they affect one side more than the other. An evaluation usually starts with an ear examination and a hearing test (audiogram), which measures how loud sounds of different pitches must be before each ear can hear them. Balance testing may be added. MRI (magnetic resonance imaging) is the key test. It can show even small tumors, their size and their relationship to nearby nerves and the brainstem, and it is also how growth is tracked over time. For a typical vestibular schwannoma, the MRI appearance is usually enough to make the diagnosis, so a biopsy (removing a tissue sample) is not always needed. Tissue examination becomes more important when a tumor looks unusual or is removed. When tumors appear on both hearing nerves or on several nerves, or symptoms begin at a young age, doctors consider whether NF2-related schwannomatosis is the underlying cause.
Treatment depends on the tumor's size, whether it is growing, the symptoms it causes, the person's age and overall health, and the experience of the treating center. For vestibular schwannoma there are three main approaches. Few studies compare them directly, so the choice is often a judgment about trade-offs rather than a single right answer. Watching with repeated MRI scans (often called wait-and-scan) suits many small tumors that cause few symptoms. Many never grow: in studies, about a third grew within three years, and about 40 percent of people eventually needed active treatment. Regular scans aim to catch growth while other options remain open. Stereotactic radiosurgery, such as Gamma Knife, aims a precisely focused dose of radiation at the tumor to stop it from growing rather than to remove it. It is generally used for small to medium tumors and keeps growth controlled for ten years in more than 90 percent of people treated. Hearing in the treated ear often declines gradually over the following years, so the chance of keeping useful hearing falls with time. Microsurgery removes the tumor through an opening in the skull. It is the preferred choice for large tumors and for tumors pressing on the brainstem or blocking the normal flow of fluid around the brain. The larger the tumor and the more completely it is removed, the higher the risk of losing hearing and of weakening the facial nerve, which moves the muscles of the face. For some large tumors, surgeons remove most of it and treat the remainder with radiosurgery to protect those nerves. No medicine shrinks a typical schwannoma. The exception is NF2-related schwannomatosis, where bevacizumab (Avastin), an intravenous drug that blocks a signal tumors use to grow new blood vessels, is sometimes used. Schwannomas on other cranial nerves are managed with the same options, adapted to the nerve involved. Optic pathway gliomas in children often need no treatment, but chemotherapy is used when vision is affected. The rare malignant tumors are managed differently, as cancers.
A cranial nerve tumor is usually a long-term condition to manage rather than a crisis. Many people with a small vestibular schwannoma go years without treatment, living with some hearing loss and returning for scans. If a tumor grows, it usually does so within the first five years after diagnosis, but some grow later, so many specialists recommend continued, less frequent scans over the long term. A tumor that keeps growing without treatment can eventually press on the brainstem and become life-threatening, which is why follow-up matters even when symptoms are mild. Hearing lost because of damage to the hearing nerve is usually permanent, whichever treatment is chosen. Hearing aids and other hearing devices can help, depending on how much hearing remains. Studies find that dizziness and unsteadiness, more than the choice of treatment, have the biggest long-term effect on quality of life, and overall quality of life looks similar after observation, radiosurgery or surgery. The first months after diagnosis are often the hardest emotionally, since being told you have a brain tumor is alarming even when it is benign. People with NF2-related schwannomatosis need lifelong care from a specialized team, because new tumors can appear and managing several at once is more complex.
See a doctor if you notice hearing loss or ringing that affects one ear more than the other, or unexplained unsteadiness, even when it seems mild. Ask for an assessment too if you develop facial numbness, facial weakness, double vision, voice changes or trouble swallowing without a clear cause. Sudden hearing loss in one ear, all at once or over a few days, needs medical attention right away, the same day if possible. A tumor is only one possible cause, but treatment for sudden hearing loss works best when it starts early. If you already have a cranial nerve tumor that is being watched or has been treated, contact your care team when symptoms change, such as worsening hearing or balance or new numbness or weakness in the face.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Cranial Nerve Tumors is like, what's helped you, or ask the community a question.